22nd Century Expands VLN® Cigarette Distribution to 150 Stores in Metro New York

Event summary

  • 22nd Century Group (Nasdaq: XXII) begins shipping VLN® cigarettes to 150 stores in metro New York and northern New Jersey.
  • The expansion targets an estimated 800,000 adult smokers in the region.
  • VLN® cigarettes are FDA-authorized as the first and only combustible cigarettes to help reduce nicotine consumption.
  • The rollout aligns with state and local smoking cessation programs like NYS Quits, NYC Quits, and New Jersey Quitline.

The big picture

This expansion positions 22nd Century to capitalize on the growing demand for reduced-nicotine tobacco products in densely populated urban areas. The strategic move aligns with broader public health initiatives aimed at smoking cessation, potentially accelerating VLN®'s market share in a high-revenue corridor. The FDA’s authorization of VLN® as a modified risk tobacco product provides a regulatory tailwind for scaling distribution.

What we're watching

Market Penetration
The pace at which 22nd Century can convert smokers in high-traffic urban markets to VLN® products.
Regulatory Alignment
Whether state-backed smoking cessation programs will amplify VLN® adoption.
Revenue Impact
How incremental high-margin revenue from this expansion affects 22nd Century’s path to cash-positive operations.

Related topics

Revenue Growth